Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Company Info
Headquarters
Number of Employees
Revenue (in millions)
Contact Info
Visit Website
Tagline
Overview
Company Services
Site Information
Contributors
Contributions
Biomanufacturing
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential Medicines
PR-M03-24-02
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
PAO-03-24-CL-03
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
PAO-03-24-CL-02
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
PR-M02-24-01
Nitrosamine Impurities
Addressing the Evolving Nitrosamine Contamination Issue
PAO-09-23-CL-07
Biocatalysis
Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme
PR-M05-23-02
CDMO Leadership Award
Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards
PR-M03-23-04
Sustainability
Olon, International API Supplier, Releases New 2022 Sustainability Report
PR-M11-22-08
Particle Engineering
Addressing Poor API Solubility with Comprehensive Particle Engineering Technology
PAO-11-022-CL-08
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
PR-M09-22-06
Business Leadership
Olon Announces the Appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division
PR-M09-22-04
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
PR-M07-22-03
R&D
Driving Further Innovation by Integrating a Decentralized R&D Network
PAO-06-022-CL-02
R&D
Olon Announces the Creation of a Major Center of Research and Development in Italy, That Will Give Rise to an Innovative Global R&D Model
PR-M05-22-10
Spray Drying
Olon Invests in New Spray Dryer at Rodano R&D Centre
PR-M05-22-11
API
CPhI Worldwide, A Significant Expansion of APIs Pipeline for Olon Group
PR-M11-21-02
Complex Chemistry
Solving Complex Chemical Problems Across All Phases of NCE Programs
PAO-10-21-CL-11
Expansion
Olon Announces A Strategic Expansion to Produce Proteins with an Advanced and Sustainable Approach
PR-M09-21-02
Sustainability
Olon Presents Its New Sustainability Manifesto
PR-M09-21-01
Expansion
Olon Announces a New Highly Potent API Expansion in Its Rodano Site
PR-M06-21-030
Italian CDMOs
Keeping Pharma Manufacturing Alive in Italy during COVID-19
PAO-04-22-R221-64
The Road to 2021
Road to 2021 Day 21: Italy, Monaco, & France
PAO-04-22-R221-48
Olon
Monte Carlo And Along The French Riviera
The Future of Healthcare
How is Olon Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
PAP-Q2-20-RT2-003
The Future of Healthcare
How is Olon Preparing to Face the Future of Healthcare?
PAP-Q1-20-R2-004
Fermentation
Supporting Customers with an Integrated Fermentation Offering
PAP-Q3-19-CL-020
Fermentation
An Integrated Fermentation Offering
PTV-M08-19-BIO-011
Acquistion
Olon Acquires Manufacturing Facility in India
PR-M09-18-NI-075
Integration
Strengthening the Outsource Service Offering through Integration
PAP-Q2-18-CL-013